Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

rrCLL × dinaciclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 rrCLL 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasms 1 Lymphoma, Mantle-Cell 1 Leukemia, Prolymphocytic 1 Leukemia, B-Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Advanced Malignant Solid Neoplasm 1

Interventions

pembrolizumab 1 dinaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02684617 2021-03-01

KEYNOTE-155

Merck Sharp & Dohme LLC

Phase 1 Terminated

75 enrolled 17 charts

rrCLL

Data powered by HemOnc (CC BY 4.0) Colophon ⚡